Sign in

CIK 0001162194 · Accelerated filer

STANDARD BIOTOOLS INC.

Sign in to watch
Ticker
LAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770513190
Phone
6502666000
Business address
50 MILK STREET, 10TH FLOOR, BOSTON, MA, 02109
Former names
FLUIDIGM CORP
  1. 4 Grant or award Chief Financial Officer acquired 1,500,000 shares (grant or award)
  2. 4 Grant or award President & CEO acquired 3,000,000 shares (grant or award)
  3. 4/A Insider Changes in Ownership
  4. 4 Grant or award Director acquired 94,592 shares (grant or award)
  5. 4 Grant or award Director acquired 94,592 shares (grant or award)
  6. 4 Grant or award Director acquired 94,592 shares (grant or award)
  7. 4 Grant or award Director acquired 94,592 shares (grant or award)
  8. 4 Grant or award Director acquired 94,592 shares (grant or award)
  9. 4 Grant or award Director acquired 94,592 shares (grant or award)
  10. 4 Shares withheld for taxes SVP & Chief Business Officer gave up 23,919 shares (to pay taxes)
  11. 4 Shares withheld for taxes President & CEO gave up 9,906 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 2,583 shares (to pay taxes)
  13. 4 Open-market sale Chief Financial Officer sold 1,428 shares at $0.94 ($1,344)
  14. 4 Open-market sale SVP & Chief Business Officer sold 13,217 shares at $0.94 ($12,437)
  15. 4 Open-market sale President & CEO sold 5,473 shares at $0.94 ($5,150)
  16. 4 Open-market sale Chief Financial Officer sold 1,355 shares at $1.00 ($1,358)
  17. 4 Open-market sale President & CEO sold 5,116 shares at $1.00 ($5,126)
  18. 4 Open-market sale SVP & Chief Business Officer sold 25,374 shares at an average $1.02 ($25,784)
  19. 4 Open-market sale President & CEO sold 4,719 shares at $1.03 ($4,861)
  20. 4 Open-market sale Chief Financial Officer sold 1,407 shares at $1.03 ($1,449)

Page 3 of 46 · 902 filings